Glamorous Family: The matters of increasing capital, sea and pharmaceuticals, and related transactions are still in progress.

Glamorous Family announced on the evening of August 20 stock trading abnormal fluctuations notice, as of the date of this announcement, the company's cash increase in Shanghai Haihe Pharmaceutical Research and Development Co., Ltd. and related transactions are still ongoing. This external investment involves new business areas, and the company made this investment decision cautiously based on strategic planning and the development prospects of the biopharmaceutical industry. However, future actual situations, such as changes in policies and regulations, changes in market environment, changes in industry competition, and changes in Haihe Drugs themselves, will all affect the operation of Haihe Drugs. If the company's understanding and tracking of the biopharmaceutical industry are insufficient, it may lead to the inability to play a proper role in post-investment management and empowerment, thus affecting investment returns.